BNP Paribas Financial Markets’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$265M Sell
2,206,233
-207,474
-9% -$24M 0.13% 153
2025
Q4
$254M Sell
2,413,707
-3,316,714
-58% -$311M 0.12% 160
2025
Q3
$481M Sell
5,730,421
-913,912
-14% -$75.3M 0.26% 63
2025
Q2
$526M Sell
6,644,333
-1,561,155
-19% -$124M 0.3% 54
2025
Q1
$737M Buy
8,205,488
+2,474,715
+43% +$231M 0.43% 34
2024
Q4
$570M Buy
5,730,773
+2,185,771
+62% +$225M 0.32% 47
2024
Q3
$403M Buy
3,545,002
+920,386
+35% +$109M 0.27% 64
2024
Q2
$325M Sell
2,624,616
-436,401
-14% -$56.2M 0.26% 76
2024
Q1
$404M Buy
3,061,017
+1,532,058
+100% +$189M 0.35% 51
2023
Q4
$167M Sell
1,528,959
-588,665
-28% -$61.1M 0.19% 111
2023
Q3
$218M Buy
2,117,624
+726,956
+52% +$78.4M 0.28% 60
2023
Q2
$160M Sell
1,390,668
-366,129
-21% -$41.6M 0.2% 94
2023
Q1
$187M Buy
1,756,797
+260,682
+17% +$28.1M 0.26% 82
2022
Q4
$166M Sell
1,496,115
-133,488
-8% -$13.6M 0.26% 81
2022
Q3
$140M Sell
1,629,603
-349,460
-18% -$31.2M 0.22% 81
2022
Q2
$180M Buy
1,979,063
+535,778
+37% +$47.5M 0.28% 72
2022
Q1
$118M Buy
1,443,285
+135,167
+10% +$10.7M 0.16% 131
2021
Q4
$100M Sell
1,308,118
-327,203
-20% -$26.1M 0.14% 150
2021
Q3
$123M Sell
1,635,321
-88,459
-5% -$6.73M 0.17% 126
2021
Q2
$134M Buy
1,723,780
+731,133
+74% +$54.4M 0.18% 131
2021
Q1
$73M Buy
992,647
+204,195
+26% +$15.1M 0.11% 206
2020
Q4
$61.5M Sell
788,452
-283,758
-26% -$21.7M 0.11% 177
2020
Q3
$84.9M Buy
1,072,210
+25,751
+2% +$2.02M 0.12% 158
2020
Q2
$77.2M Sell
1,046,459
-1,019,226
-49% -$76.7M 0.14% 147
2020
Q1
$152M Buy
2,065,685
+1,512,756
+274% +$119M 0.31% 59
2019
Q4
$48M Sell
552,929
-2,115,974
-79% -$174M 0.09% 241
2019
Q3
$214M Buy
2,668,903
+1,435,713
+116% +$115M 0.38% 50
2019
Q2
$98.7M Buy
1,233,190
+505,693
+70% +$38.7M 0.2% 114
2019
Q1
$57.7M Sell
727,497
-973,389
-57% -$72.8M 0.12% 174
2018
Q4
$124M Sell
1,700,886
-1,907,461
-53% -$135M 0.29% 61
2018
Q3
$244M Buy
3,608,347
+228,846
+7% +$14.6M 0.36% 43
2018
Q2
$196M Buy
3,379,501
+1,798,368
+114% +$101M 0.33% 51
2018
Q1
$82.2M Sell
1,581,133
-330,774
-17% -$17.9M 0.15% 123
2017
Q4
$103M Sell
1,911,907
-1,569,805
-45% -$87M 0.18% 110
2017
Q3
$213M Buy
3,481,712
+1,110,912
+47% +$67.4M 0.52% 32
2017
Q2
$145M Sell
2,370,800
-327,361
-12% -$19.9M 0.44% 44
2017
Q1
$164M Buy
2,698,161
+1,281,705
+90% +$77.8M 0.43% 47
2016
Q4
$79.6M Buy
1,416,456
+76,871
+6% +$4.5M 0.37% 50
2016
Q3
$79.8M Buy
1,339,585
+413,831
+45% +$24.2M 0.33% 64
2016
Q2
$50.9M Buy
925,754
+24,935
+3% +$1.33M 0.23% 65
2016
Q1
$45.5M Sell
900,819
-1,552,322
-63% -$76M 0.19% 92
2015
Q4
$124M Sell
2,453,141
-158,927
-6% -$8.01M 0.3% 64
2015
Q3
$123M Sell
2,612,068
-664,787
-20% -$35.3M 0.31% 49
2015
Q2
$178M Buy
3,276,855
+2,463,265
+303% +$138M 0.5% 36
2015
Q1
$44.6M Sell
813,590
-1,285,030
-61% -$72.8M 0.12% 104
2014
Q4
$114M Sell
2,098,620
-314,954
-13% -$17.5M 0.4% 44
2014
Q3
$137M Buy
2,413,574
+665,708
+38% +$37.4M 0.12% 107
2014
Q2
$96.5M Sell
1,747,866
-366,296
-17% -$20M 0.09% 115
2014
Q1
$118M Sell
2,114,162
-75,896
-3% -$3.93M 0.09% 110
2013
Q4
$105M Sell
2,190,058
-489,846
-18% -$22.4M 0.08% 123
2013
Q3
$122M Buy
2,679,904
+2,202,634
+462% +$101M 0.09% 130
2013
Q2
$21.2M Buy
+477,270
New +$21.3M 0.02% 228

Other funds holding MRK

BNP Paribas Financial Markets's MRK Position: Q1 2026 in Review

BNP Paribas Financial Markets reduced its Merck (MRK) stake by 8.6% in Q1 2026, selling an estimated $24M and leaving 2,206,233 shares worth $265M. The position accounts for 0.13% of the portfolio, ranked #153.

BNP Paribas Financial Markets first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $737M in Q1 2025. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • BNP Paribas Financial Markets held 2,206,233 shares of Merck worth $265M as of Q1 2026.
  • BNP Paribas Financial Markets sold 207,474 Merck shares in Q1 2026, an estimated $24M.
  • Merck made up 0.13% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #153 holding.
  • BNP Paribas Financial Markets first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • BNP Paribas Financial Markets's Merck position peaked at $737M in Q1 2025.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.